STERIS Plc (Ireland)

{
  "main_header": {
    "sid": 1248994,
    "name": "STERIS Plc (Ireland)",
    "stock_name": "STERIS Plc (Ireland)",
    "full_name": "STERIS Plc (Ireland)",
    "name_url": "stocks-analysis/steris-plc-ireland",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "259.52",
    "chg": -1.38,
    "chgp": "-0.53%",
    "dir": -1,
    "prev_price": "260.90",
    "mcapval": "25,634.04",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "IE00BFY8C754",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "277.95 k",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/steris-plc-ireland-1248994-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "STERIS Plc Experiences Valuation Adjustment Amid Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/steris-plcs-valuation-grade-changes-from-fair-to-expensive-amidst-competitive-landscape-3667185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/STERISPlcIrelan_valuationdot_3667185.png",
        "date": "2025-11-03 16:10:23",
        "description": "STERIS Plc, a midcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation metrics, with a P/E ratio of 34 and a price-to-book value of 3.63. The company has experienced a year-to-date return of 14.66%, though it lags behind the S&P 500. Its dividend yield is 0.92%."
      }
    ],
    "total": 11,
    "sid": "1248994",
    "stock_news_url": "https://www.marketsmojo.com/news/steris-plc-ireland-1248994"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

STERIS Plc Experiences Valuation Adjustment Amid Competitive Market Landscape

2025-11-03 16:10:23

STERIS Plc, a midcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation metrics, with a P/E ratio of 34 and a price-to-book value of 3.63. The company has experienced a year-to-date return of 14.66%, though it lags behind the S&P 500. Its dividend yield is 0.92%.

Read full news article

View All News